Preferences for Follow-Up Procedures among Patients Lost to Follow-Up after Smoking Cessation Intervention among Therapists-An Interview Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 27 03 2024
revised: 17 05 2024
accepted: 25 05 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Achieving high follow-up rates after smoking cessation interventions (SCIs) is a general challenge. The aim of this study was to identify preferences among patients and therapists for improving follow-up rates and to assess smoking status at 6 months among patients lost to follow-up. From the Danish STOPbase for Tobacco and Nicotine, which collects data on SCI across health care, 20 representative patients lost to follow-up by routine procedures were identified together with 11 therapists. All participated in individual semi-structured phone interviews, which for patients also included 6-month smoking status. Deductive and inductive analyses were performed. Four themes emerged from the analyses with several subthemes, all regarding contacts. Both patients and therapists preferred to intensify the follow-up process by boosting it with additional attempts and using voice messages, e-mail and/or SMS, calling at specified times of the day and avoiding calls from unknown numbers. In addition, some patients mentioned that they were busy or were not carrying their mobile devices at the time of a call as a barrier. Some therapists mentioned that barriers could include an expectation of relapse, but also a poor mental state, the time of day and patient fear of public systems. Among the patients originally lost to follow-up, 35% (95% CI 16%-59%) experienced continuous smoking cessation for 6 months, and the overall national rate was 22% (21.6-23.3%). In conclusion, both patients and therapists preferred intensified follow-up. The 6-month smoking status for patients lost to follow-up seemed to be similar to that of the routinely followed-up patients. These findings will be examined experimentally in a larger study.

Identifiants

pubmed: 38928972
pii: ijerph21060726
doi: 10.3390/ijerph21060726
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The Oak Foundation
ID : OCAY-18-774-OFIL

Auteurs

Sanne Wärjerstam (S)

WHO Collaborating Centre, Clinical Health Promotion Centre, Research Unit for Dietary Studies, The Parker Institute, Bispebjerg & Frederiksberg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark.

Camilla Dew-Hattens (C)

WHO Collaborating Centre, Clinical Health Promotion Centre, Research Unit for Dietary Studies, The Parker Institute, Bispebjerg & Frederiksberg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark.

Mette Rasmussen (M)

WHO Collaborating Centre, Clinical Health Promotion Centre, Research Unit for Dietary Studies, The Parker Institute, Bispebjerg & Frederiksberg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark.
National Institute of Public Health, University of Southern Denmark, DK-1455 Copenhagen, Denmark.

Berit Lilienthal Heitmann (BL)

WHO Collaborating Centre, Clinical Health Promotion Centre, Research Unit for Dietary Studies, The Parker Institute, Bispebjerg & Frederiksberg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark.
Section for General Practice, Department of Public Health, University of Copenhagen, DK-1172 Copenhagen, Denmark.

Rie Raffing (R)

WHO Collaborating Centre, Clinical Health Promotion Centre, Research Unit for Dietary Studies, The Parker Institute, Bispebjerg & Frederiksberg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark.

Hanne Tønnesen (H)

WHO Collaborating Centre, Clinical Health Promotion Centre, Research Unit for Dietary Studies, The Parker Institute, Bispebjerg & Frederiksberg Hospital, University of Copenhagen, DK-2400 Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH